This Fast Track Designation will enable FDA to review MM-II in an expedited manner, is an important milestone in the development of MM-II
Provides pain relief for more than 30 conditions, including chronic back pain, arthritis, and sports injuries
Call it a ray of hope for those enduring the pain of knee osteoarthritis -- the most common form of arthritis, affecting over 300 million people worldwide
AGEasy has made significant strides in addressing the pressing health concerns of seniors in India
Partners with Yifan Pharmaceutical to launch Synovian injection for osteoarthritis in China
The data from this study show that MM-II has the potential to provide durable pain relief for our patients
For discovery or for standardization, Ayurveda colleges/institutes need to collaborate closely with Phytochemists, Pharmacologists, and Toxicologists from premier institutions
Ascent Meditech has set benchmarks in introducing pain management products in India. The company has embarked on a new marketing campaign as it plans to enter new markets. Rajiv Mistry, Founder & Managing Director, Ascent Group shares his perspective with Thomas C Thottathil on the road ahead for the company and industry
Subscribe To Our Newsletter & Stay Updated
